Clinical trial
A Phase II Study of UCN-01 in Metastatic Melanoma
NCT00072189 · National Cancer Institute (NCI), NIH · Terminated
Key facts
| NCT number | NCT00072189 |
|---|---|
| Title | A Phase II Study of UCN-01 in Metastatic Melanoma |
| Official title | A Phase II Study of UCN-01 in Metastatic Melanoma |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Recurrent Melanoma, Stage IV Melanoma |
| Intervention type | Drug, Other |
| Interventions | 7-hydroxystaurosporine, laboratory biomarker analysis, pharmacological study |
| Enrollment | 17 |
| Start date | Nov 1, 2003 |
| Primary completion | Mar 1, 2010 |
| Completion | Mar 1, 2010 |
| First posted | Nov 6, 2003 |
| Last update posted | Mar 2, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: